Investing.com - EDAP reported on Tuesday first quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
EDAP announced earnings per share of €0.03 on revenue of €10.3M (NYSE:MMM). Analysts polled by Investing.com anticipated EPS of €0.00 on revenue of €10.53M.
EDAP shares are up 23.4% from the beginning of the year and are trading at €6.38 , down-from-52-week-high.They are outperforming the Nasdaq which is up 3.89% from the start of the year.
EDAP follows other major Healthcare sector earnings this month
EDAP's report follows an earnings beat by J&J on Tuesday, April 20, 2021, who reported EPS of €2.59 on revenue of €22.32B, compared to forecasts EPS of €2.34 on revenue of €21.98B.
Pfizer had beat expectations on Tuesday, May 4, 2021 with first quarter EPS of €0.93 on revenue of €14.58B, compared to forecast for EPS of €0.7759 on revenue of €13.65B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar